← Eichor
Study identifier: NCT03546231 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

Condition: Tricuspid Valve Disease  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseN/A
Planned participants400
Who can joinAll sexes, 18 Months to no upper limit
Healthy volunteersNo

About this study

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

This description comes directly from the study's public registry record.

Talk to the study team

Christophe TRIBOUILLOY, Pr  ·  03 22 45 58 85  ·  Tribouilloy.Christophe@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Amiens-PicardieAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03546231